Fluorouracil (5FU) is a type of chemotherapy used to help treat several types of cancer. Side effects may include dizziness, nausea, and low blood count, among others. Cancer is a disease where cells ...

Please provide your email address to receive an email when new articles are posted on . Surgical excision, 5-fluorouracil cream and MAL-PDT were compared in Bowen’s disease treatment. Sustained ...

Deleted in Colon Cancer Protein Expression in Colorectal Cancer Metastases: A Major Predictor of Survival in Patients With Unresectable Metastatic Disease Receiving Palliative Fluorouracil-Based ...

Fluorouracil is not recommended for use in patients known to have certain homozygous or compound heterozygous DPYD variants that result in complete DPD deficiency. The Food and Drug Administration ...

Oncology specialists should inform patients about a risk of serious toxicity related to dihydropyrimidine dehydrogenase (DPD) deficiency and should test for DPYD variants before starting treatment ...

Review the side-effects of Fluorouracil as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

Fluorouracil (Fluracil (500 mg)) is an antimetabolite, prescribed for certain types of cancer such as colon, rectal, breast, stomach and pancreatic cancer. It works by blocking the growth of certain ...

This double-blind, phase III study aimed to demonstrate that sunitinib plus FOLFIRI (fluorouracil, leucovorin, and irinotecan) was superior to placebo plus FOLFIRI in previously untreated metastatic ...

Actinic keratoses are common in older individuals and topical immunotherapy is an important treatment when multiple lesions are present. To assess the efficacy of 5-fluorouracil in treating actinic ...

The U.S. Food and Drug Administration is warning pet owners of the risks associated with a skin cancer cream after five dogs were died after accidentally ingesting it. The topical cancer medication ...

Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, has shown promising preclinical and clinical activity against metastatic colorectal cancer, particularly in combination ...